BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 7:03:59 AM | Browse: 509 | Download: 1233
 |
Received |
|
2022-02-11 01:43 |
|
Peer-Review Started |
|
2022-02-11 01:46 |
|
First Decision by Editorial Office Director |
|
2022-05-30 00:52 |
|
Return for Revision |
|
2022-05-30 00:52 |
|
Revised |
|
2022-06-02 16:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-20 03:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-26 22:40 |
|
Articles in Press |
|
2022-06-26 22:40 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-06-30 08:36 |
|
Publish the Manuscript Online |
|
2022-07-22 07:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Early detection of circulating tumor DNA and successful treatment with osimertinib in thr790met-positive leptomeningeal metastatic lung cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Qing Xu, Ying-Jin Wang, Sheng-Li Shen, Yao Wu and Hong-Zhou Duan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hong-Zhou Duan, Doctor, PhD, Chief Doctor, Department of Neurosurgery, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing 100034, Beijing, Djibouti. duanhongzhou@126.com |
| Key Words |
Non-small cell lung cancer; Epidermal growth factor receptor mutation; Circulating tumor DNA detection; Leptomeningeal carcinomatosis; Osimertinib; Case report |
| Core Tip |
Examination of circulating tumor DNA in cell-free cell-free cerebrospinal fluid (CSF) has been shown to be useful for detecting the genomic mutations of tumors in the central nervous system, and osimertinib is considered to be a recent standardized treatment for epidermal growth factor receptor (EGFR) Thr790Met-mutant non-small-cell lung cancer (NSCLC). Hence, we report a patient with EGFR Thr790Met-mutant NSCLC with meningeal carcinomatosis and resistance to gefitinib and propose that the positive findings of CSF circulating tumor DNA as a liquid biopsy technology based on the detection of cancer-associated gene mutations that may appear earlier than the imaging and CSF findings and thus be helpful for therapy. |
| Publish Date |
2022-07-22 07:03 |
| Citation |
Xu L, Wang Y, Shen S, Wu Y, Duan H. Early detection of circulating tumor DNA and successful treatment with osimertinib in thr790met-positive leptomeningeal metastatic lung cancer: A case report. World J Clin Cases 2022; 10(22): 7968-7972 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i22/7968.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i22.7968 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
